A 2025 systematic review mapped weight change after stopping anti-obesity medicines across 11 RCTs
For example, a case report showed that a 24-week course of liraglutide in a 62-year-old male with HIV, obesity, type 2 diabetes, and moderate OSA managed with CPAP reduced his AHI from 27 to 7.1
each row is a what-if based on public trial status and typical FDA clocks
Clinical studies show maximal reduction in ALT levels (a marker of liver damage) was achieved approximately 28-30 weeks after starting treatment 20
When respiratory symptoms do occur in patients taking GLP-1 medications, they are more commonly attributable to complications of treatment rather than the medication itself
Liraglutide 3 mg on weight, body composition, and hormonal and metabolic parameters in women with obesity and polycystic ovary syndrome: a randomized placebo-controlled-phase 3 study